Elevated expression levels of IL-37 have been observed in lung adenocarcinoma (LUAD) tumors, and the expression profiles of both IL-37 and its receptor SIGIRR are correlated with LUAD development and tumor stage [10]. The gene discussed is IL37; the disease is lung adenocarcinoma.